Article · 29 Aug 2026
Conference abstract
Development of new biotechnology platforms for production of HPV vaccines: Approaches in the context of developing countries
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
P ersistent infection with high-risk Human Papillomavirus (HPV) is an essential factor in the development of cervical cancer and also a contributory factor for vulvar, vaginal, penile, anal, head and neck (oropharyngeal) cancers. More than 80% of these cases occur in developing world. The current prophylactic HPV vaccines provide protection against the -16 and -18 genotypes which are most commonly associated with cervical cancer worldwide. Although the proven efficacy, the introduction of a vaccination program with these vaccines is a challenge due to their high costs, social barriers and the potential for new oncogenic strains to emerge. Furthermore, a therapeutic vaccine is needed for women already affected by HPV-related cancer. In this manner, we have developed a cost effectiveness platform based on Pichia pastoris yeast and non commercial vectors for production of multiple HPV Virus-like Particles (VLPs) types with prophylactic purposes. In parallel, different DNA vectors based on epitopes of E5 HPV oncogene were constructed for evaluation of therapeutic strategies through genetic immunization. The immunological activities of these approaches are now under evaluation in animal models. The development of these platforms is an important step for establishment of alternatives vaccinal strategies against HPV in the context of financial constraints, lack of adequate infrastructure and the competing priorities found in the developing countries.
Keywords
Subjects
Vaccines & ImmunisationAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Vaccines & Vaccination.
Article · 29 Aug 2026
Advances in Adjuvant Development for Enhanced Vaccine Performance and Long-Term Immune Protection
Article · 20 Jun 2026
Herd Immunity and Its Role in Controlling Infectious Diseases
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Vaccines & Vaccination
- SubjectVaccines & Immunisation
- BylineArticles whose byline prints “Filipe Colaco Mariz”